Digital Health Europe

Europe Aging in Place Technology Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Europe Aging in Place Technology Market Industry Trends and Forecast to 2034: Segmented by (Product, Payer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.31 Bn Placeholder estimate
Estimate 2025 $1.45 Bn 19.3% of the global market
Projected 2034 $3.74 Bn 157.9% Adds $2.29 Bn over 9 forecast years
CAGR 2025–2034 11.1% Faster than 29% of 100 Digital Health markets here
Key players 6 +1
  • Europe is 19.26% of the global market.
  • Among regions, the largest is North America at $4.11 Bn.
  • Fastest growing: Africa at 13.6% a year.
  • Europe ranks 2nd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.29 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Aging in Place Technology Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.31 Bn — —
2025 (base) $1.45 Bn +$144.9 Mn —
2026 (forecast) $1.61 Bn +$160.9 Mn +11.1%
2027 (forecast) $1.79 Bn +$178.8 Mn +23.4%
2028 (forecast) $1.99 Bn +$198.7 Mn +37.1%
2029 (forecast) $2.21 Bn +$220.7 Mn +52.4%
2030 (forecast) $2.45 Bn +$245.2 Mn +69.3%
2031 (forecast) $2.73 Bn +$272.4 Mn +88.1%
2032 (forecast) $3.03 Bn +$302.7 Mn +108.9%
2033 (forecast) $3.37 Bn +$336.3 Mn +132.1%
2034 (forecast) $3.74 Bn +$373.6 Mn +157.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Aging in Place Technology Market Analysis at a glance
Market size, 2025$1.45 Bn placeholder estimate
Forecast, 2034$3.74 Bn placeholder estimate
Growth (CAGR), 2025–203411.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, payer and end user (see all)
Key playersPhilips Healthcare, Best Buy Health (Lively), Medical Guardian, Vayyar, CarePredict and 1 more (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
Active clinical trials188 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Aging in Place Technology Market Analysis Executive Summary

Aging in place technology helps older adults live safely at home, with fall detection, smart sensors, medication reminders and remote check-ins.

Key segments of the aging in Place Technology market include product (Fall Detection and PERS, Smart Home Sensors and Medication Management) and payer (Self-Pay, Insurance and Government Programs).

Bar chart: Europe Aging in Place Technology market size, 2024–2034, placeholder estimates. $1.31 Bn in 2024, $1.45 Bn in 2025 and $3.74 Bn in 2034, 11.1% CAGR.
Europe Aging in Place Technology market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Aging in Place Technology Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the aging in Place Technology market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the aging in Place Technology market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the aging in Place Technology market.

Competitive Landscape for Aging in Place Technology Market in Europe

The aging in Place Technology market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Aging in Place Technology Market in Europe

Aging in Place Technology in Europe: rules, payment and research

Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device.⁠[1] In some of the countries we cover here, rules for health software come from EU MDR and ANSM (France)⁠[1], BfArM (DiGA) (Germany)⁠[2], EU MDR and Ministry of Health (Italy)⁠[1], EU MDR and AEMPS (Spain)⁠[1] and MHRA (UK)⁠[3]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[4] ClinicalTrials.gov lists 188 studies on Aging in Place Technology that are recruiting, active or about to start in Europe.⁠[5]

[1] European Commission, medical devices. Checked 14 Nov 2026.

[2] BfArM DiGA directory. Checked 14 Nov 2026.

[3] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[4] European Commission, health technology assessment. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the aging in Place Technology market. Government digital health programs in Europe are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Aging in Place Technology right now, from free public sources.

Clinical trials

188 active trials in UK, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Denmark, Poland, Turkey and Russia

Recruiting, about to start, or running now. Counted across the 13 countries we report on in Europe.

Top trial sponsors (worldwide)

  1. Amazentis SA 4 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Teoxane 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. L'Oreal 3 active trials on ClinicalTrials.gov (opens in a new tab)
  4. DSM-Firmenich 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Longevity Metrics, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Patients

People aged 65 and over, % of people (World Bank)
CountryValueYear
Belgium21.02025
Denmark21.12025
France22.52025
Germany23.72025
Italy25.12025
Netherlands20.92025
Poland20.82025
Russia17.82025
Spain21.62025
Sweden20.92025
Switzerland20.42025
Turkey10.62025
UK19.72025
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 19 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Aging in Place Technology in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Aging in Place Technology market in Europe?
Placeholder estimate: about $1.45 Bn in 2025, rising to about $3.74 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Aging in Place Technology market in Europe growing?
Placeholder estimate: about 11.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Aging in Place Technology market report cover?
The report splits the market by product (Fall Detection and PERS, Smart Home Sensors, Medication Management, Telehealth Devices), payer (Self-Pay, Insurance, Government Programs) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the Aging in Place Technology market?
Key players include Philips Healthcare, Best Buy Health (Lively), Medical Guardian, Vayyar, CarePredict and ADT.
What is driving the Aging in Place Technology market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the aging in Place Technology market. Older adults and their families are spending more on staying active and independent.
Who regulates Aging in Place Technology in Europe?
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Aging in Place Technology are running in Europe?
188 studies are recruiting, active or about to start in Europe, counted across the 13 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Aging in Place Technology?
PubMed lists 166 papers on Aging in Place Technology added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in Europe

See all

Related on geriatric and home and long-term care

See the topic